Perrigo (PRGO) Other Non Operating Income (2013 - 2026)

Perrigo's (PRGO) quarterly Other Non Operating Income came in at $6.0 million in Q1 2026, up 1400.0% year-on-year from $400000.0 in Q1 2025, and up 561.54% on a QoQ basis from -$1.3 million in Q4 2025.

Perrigo (PRGO) Other Non Operating Income (2013 - 2026) Analysis & Trends

Perrigo (PRGO) has 14 years of Other Non Operating Income data on file, last reported at $6.0 million in Q1 2026.

  • On a quarterly basis, Other Non Operating Income rose 1400.0% year-over-year to $6.0 million in Q1 2026; TTM through Mar 2026 was $2.1 million, a 121.88% increase from a year earlier, with the FY2025 full-year figure at -$13.2 million, down 97.01% from the prior year.
  • Other Non Operating Income for Q1 2026 stood at $6.0 million, up from -$1.3 million in the prior quarter.
  • Over the last five years, Other Non Operating Income for PRGO reached as high as $9.7 million in Q3 2023 and fell as low as -$9.3 million in Q3 2022.
  • Historically, Other Non Operating Income has averaged -$913333.3 across 5 years, with a median of -$1.3 million in 2025.
  • Across the five-year window, Other Non Operating Income plunged 145.45% in 2023 and surged 1400.0% in 2026, its largest moves.
  • Year by year, Other Non Operating Income stood at -$4.4 million in 2022, then sank by 45.45% to -$6.4 million in 2023, then surged by 76.56% to -$1.5 million in 2024, then advanced by 13.33% to -$1.3 million in 2025, then surged by 561.54% to $6.0 million in 2026.
  • Per Business Quant data, the three most recent Other Non Operating Income figures were $6.0 million in Q1 2026, -$1.3 million in Q4 2025, and -$2.6 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 88.07 Bn 86.20 Bn -
2 Teva Pharmaceutical Industries 35.75 Bn 32.01 Bn 1.97 Bn
3 Zoetis 31.84 Bn 29.90 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.18 Bn 23.12 Bn 4.39 Bn
5 United Therapeutics 23.09 Bn 20.93 Bn 648.10 Mn
6 RedHill Biopharma 21.32 Bn 21.32 Bn -
7 Viatris 19.96 Bn 18.16 Bn 1.16 Bn
8 Neurocrine Biosciences 17.66 Bn 16.34 Bn 800.70 Mn
9 Elanco Animal Health 12.44 Bn 12.02 Bn 785.00 Mn
10 Perrigo 1.40 Bn 1.04 Bn 325.50 Mn

Historic Data

Download Data
DateValue
Mar 28, 2026 6.00 Mn
Dec 31, 2025 -1.30 Mn
Jun 28, 2025 -2.60 Mn
Mar 29, 2025 400,000.00
Dec 31, 2024 -1.50 Mn
Sep 28, 2024 -5.10 Mn
Jun 29, 2024 -3.40 Mn
Mar 30, 2024 -400,000.00
Dec 31, 2023 -6.40 Mn
Jul 1, 2023 9.70 Mn
Apr 1, 2023 -500,000.00
Dec 31, 2022 -4.40 Mn
Oct 1, 2022 4.00 Mn
Jul 2, 2022 -9.30 Mn
Apr 2, 2022 1.10 Mn
Dec 31, 2021 -18.50 Mn
Apr 3, 2021 -2.40 Mn
Dec 31, 2020 1.60 Mn
Sep 26, 2020 -20.00 Mn
Jun 27, 2020 -17.10 Mn